ClinicalTrials.gov record
Completed Early Phase 1 Interventional Accepts healthy volunteers Results available

Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075

ClinicalTrials.gov ID: NCT03248947

Public ClinicalTrials.gov record NCT03248947. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 7:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: Clinical Trials Network 0075

Study identification

NCT ID
NCT03248947
Recruitment status
Completed
Study type
Interventional
Phase
Early Phase 1
Lead sponsor
Duke University
Other
Enrollment
71 participants

Conditions and interventions

Interventions

  • Pharmacist-administered buprenorphine/naloxone maintenance care Other
  • buprenorphine/naloxone Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 27, 2018
Primary completion
Jun 26, 2019
Completion
Jun 26, 2019
Last update posted
Jul 27, 2021

2018 – 2019

United States locations

U.S. sites
6
U.S. states
1
U.S. cities
2
Facility City State ZIP Site status
Duke Outpatient Clinic Durham North Carolina 27704
Josefs Pharmacy Durham North Carolina 27704
Changes by Choice Durham North Carolina 27705
Clinic Pharmacy Durham North Carolina 27705
Carolina Performance Raleigh North Carolina 27615
Health Park Pharmacy Raleigh North Carolina 27615

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03248947, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 27, 2021 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03248947 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →